Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Nei-Yuan Hsiao

Biographic Data

ID7731695
NAMENei-Yuan Hsiao
GIVEN NAMESNei-Yuan
FAMILY NAMEHsiao
SIGNATUREHSIAO N
AFFILIATIONSNational Health Laboratory Service
ORCID0000-0003-4926-6216
VERIFIEDYes
TOTAL WORKS12
TOTAL CITATIONS0
WORKS AS AUTHOR3
WORKS AS EDITOR9
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Trends in advanced HIV disease, treatment interruption, and viraemia in KwaZulu-Natal, South Africa

    Open Access•Sanele S Mbeje, Lilishia Gounder et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    Advanced HIV disease (AHD), treatment interruption and viraemia remain key challenges to effectiveness of HIV programmes in South Africa. Understanding the trends of these measures and their variation across geographic regions can inform more targeted and responsive interventions. We conducted a retrospective cohort study using routine, de-identified data from TIER.Net, a national HIV electronic register. We curated data from 116 primary care cli…

  • Decade-long antiretroviral therapy in Uganda

    Open Access•Maria Magdalene Namaganda, Stathis Gennatas et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    The scale-up of antiretroviral therapy (ART) has transformed the HIV epidemic in sub-Saharan Africa, yet longitudinal public health insights from national programmatic cohorts remain scarce. As global targets move toward epidemic control and elimination of virological failure, understanding how profiles and outcomes of people living with HIV (PLWH) evolve in real-world settings is essential. The AIDS Support Organisation (TASO), Uganda’s largest …

  • Does enhanced HIV prevention, diagnosis, and linkage to care reduce hospitalisation in high HIV-burden communities in Zambia and South Africa? findings from the HPTN 071 (PopART) randomised trial

    Open Access•Ronelle Burger, Nomtha Bell‐Mandla et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    The objective of this study is to explore if a community-based HIV combination prevention intervention reduced inpatient hospitalisations in Zambia and South Africa by diagnosing HIV and TB in earlier stages of disease progression, thereby preventing severe disease and new infections. As part of the HIV Prevention Trials Network (HPTN) 071 trial, hospitalisation data from a cohort of 16 968 consenting randomly sampled adults aged 18–44 years were…

  • High prevalence of undocumented Sars-CoV-2 infections revealed by analysis of nucleocapsid-specific IgG responses in diagnosed and undiagnosed individuals

    Open Access•Kim Blom, Ilias Galanis et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    Acute SARS-CoV-2 infections are not always diagnosed; hence an unknown proportion of all infections are not documented. SARS-CoV-2 can induce spike and nucleocapsid protein specific IgG antibodies, which can be detected in seroprevalence studies to identify a previous infection. However, with the introduction of vaccines containing the spike protein it is no longer possible to use spike-IgG as a marker of infection. In many countries marketed vac…

  • Sars-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities

    Open Access•Hannah Hussey, Helena Vreede et al.•ARTICLE•PLOS Global Public Health•2024

    In low- and middle-income countries where SARS-CoV-2 testing is limited, seroprevalence studies can help describe and characterise the extent of the pandemic, as well as elucidate protection conferred by prior exposure. We conducted repeated cross-sectional serosurveys (July 2020 –November 2021) using residual samples from patients from Cape Town, South Africa, sent for routine laboratory studies for non-COVID-19 conditions. SARS-CoV-2 anti-nucle…

  • Diagnostic testing preferences can help inform future public health response efforts

    Open Access•Leah Salzano, Nithya Narayanan et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    Public perception regarding diagnostic sample types as well as personal experiences can influence willingness to test. As such, public preferences for specific sample type(s) should be used to inform diagnostic and surveillance testing programs to improve public health response efforts. To understand where preferences lie, we conducted an international survey regarding the sample types used for SARS-CoV-2 tests. A Qualtrics survey regarding SARS-…

  • Evaluation of inflammation adjustment methods to assess iron deficiency using longitudinal data from norovirus human challenge trials

    Open Access•Yi‐An Ko, Parminder S Suchdev et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    Accounting for inflammation is necessary to assess iron deficiency using ferritin. A limitation of existing inflammation-adjustment methods is reliance on cross-sectional data to evaluate method performance. The study objective was to evaluate three inflammation-adjustment methods using longitudinal data from two controlled trials where apparently healthy adults (n = 52) were exposed to norovirus. Correction factors (CF), the Biomarkers Reflectin…

  • Mild and moderate Covid-19 during Alpha, Delta and Omicron pandemic waves in urban Maputo, Mozambique, December 2020-March 2022

    Open Access•Brecht Ingelbeen, Victoria Cumbane et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    In sub-Saharan Africa, reported COVID-19 numbers have been lower than anticipated, even when considering populations’ younger age. The extent to which risk factors, established in industrialised countries, impact the risk of infection and of disease in populations in sub-Saharan Africa, remains unclear. We estimated the incidence of mild and moderate COVID-19 in urban Mozambique and analysed factors associated with infection and disease in a popu…

  • Comparison of commercially available, rapid, point-of-care C-reactive protein assays among children with febrile illness in southwestern Uganda

    Open Access•Caitlin A Cassidy, Lydiah Kabugho et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    In Uganda, children with febrile illness are often treated with antibiotics even though most have self-limiting, likely viral, infections. C-reactive protein (CRP) measurement can help identify those who are more likely to have a bacterial infection and therefore need antibiotic treatment. Implementation of a CRP rapid diagnostic test (RDT) at the point-of-care in resource-constrained settings with minimal laboratory infrastructure could reduce u…

  • Continuous quality evaluation of the Asanté rapid test for recent infection for robust kit lot quality verification

    Open Access•Amy Zheng, Mervi Detorio et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    The Sedia Biosciences Asanté rapid test for recent infection (RTRI) can identify HIV infections and characterize HIV-1 as recent or long-term infection via the positive verification (V) line and long-term line (LT) line, respectively. Tracking with Recency Assays to Control the Epidemic (TRACE) program uses RTRI assays. Successful implementation of TRACE requires high-quality test performance. The goal of this study is to evaluate the additional …

  • Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots

    Open Access•Christopher M Ferraris, Paul D’Avanzo et al.•ARTICLE•AIDS and Behavior•2023

  • Mixed-method estimation of population-level HIV viral suppression rate in the Western Cape, South Africa

    Open Access•Elton Mukonda, Nei-Yuan Hsiao et al.•ARTICLE•BMJ Global Health•2020

    INTRODUCTION: There are few population-wide data on viral suppression (VS) that can be used to monitor programmatic targets in sub-Saharan Africa. We describe how routinely collected viral load (VL) data from antiretroviral therapy (ART) programmes can be extrapolated to estimate population VS and validate this using a combination of empiric and model-based estimates. METHODS: VL test results from were matched using a record linkage algorithm to …

No prominent works on this page.

  • Mixed-method estimation of population-level HIV viral suppression rate in the Western Cape, South Africa

    Open Access•Elton Mukonda, Nei-Yuan Hsiao et al.•ARTICLE•BMJ Global Health•2020

    INTRODUCTION: There are few population-wide data on viral suppression (VS) that can be used to monitor programmatic targets in sub-Saharan Africa. We describe how routinely collected viral load (VL) data from antiretroviral therapy (ART) programmes can be extrapolated to estimate population VS and validate this using a combination of empiric and model-based estimates. METHODS: VL test results from were matched using a record linkage algorithm to …

  • Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots

    Open Access•Christopher M Ferraris, Paul D’Avanzo et al.•ARTICLE•AIDS and Behavior•2023

  • Sars-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities

    Open Access•Hannah Hussey, Helena Vreede et al.•ARTICLE•PLOS Global Public Health•2024

    In low- and middle-income countries where SARS-CoV-2 testing is limited, seroprevalence studies can help describe and characterise the extent of the pandemic, as well as elucidate protection conferred by prior exposure. We conducted repeated cross-sectional serosurveys (July 2020 –November 2021) using residual samples from patients from Cape Town, South Africa, sent for routine laboratory studies for non-COVID-19 conditions. SARS-CoV-2 anti-nucle…

  • Diagnostic testing preferences can help inform future public health response efforts

    Open Access•Leah Salzano, Nithya Narayanan et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    Public perception regarding diagnostic sample types as well as personal experiences can influence willingness to test. As such, public preferences for specific sample type(s) should be used to inform diagnostic and surveillance testing programs to improve public health response efforts. To understand where preferences lie, we conducted an international survey regarding the sample types used for SARS-CoV-2 tests. A Qualtrics survey regarding SARS-…

  • Evaluation of inflammation adjustment methods to assess iron deficiency using longitudinal data from norovirus human challenge trials

    Open Access•Yi‐An Ko, Parminder S Suchdev et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    Accounting for inflammation is necessary to assess iron deficiency using ferritin. A limitation of existing inflammation-adjustment methods is reliance on cross-sectional data to evaluate method performance. The study objective was to evaluate three inflammation-adjustment methods using longitudinal data from two controlled trials where apparently healthy adults (n = 52) were exposed to norovirus. Correction factors (CF), the Biomarkers Reflectin…

  • Mild and moderate Covid-19 during Alpha, Delta and Omicron pandemic waves in urban Maputo, Mozambique, December 2020-March 2022

    Open Access•Brecht Ingelbeen, Victoria Cumbane et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    In sub-Saharan Africa, reported COVID-19 numbers have been lower than anticipated, even when considering populations’ younger age. The extent to which risk factors, established in industrialised countries, impact the risk of infection and of disease in populations in sub-Saharan Africa, remains unclear. We estimated the incidence of mild and moderate COVID-19 in urban Mozambique and analysed factors associated with infection and disease in a popu…

  • Comparison of commercially available, rapid, point-of-care C-reactive protein assays among children with febrile illness in southwestern Uganda

    Open Access•Caitlin A Cassidy, Lydiah Kabugho et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    In Uganda, children with febrile illness are often treated with antibiotics even though most have self-limiting, likely viral, infections. C-reactive protein (CRP) measurement can help identify those who are more likely to have a bacterial infection and therefore need antibiotic treatment. Implementation of a CRP rapid diagnostic test (RDT) at the point-of-care in resource-constrained settings with minimal laboratory infrastructure could reduce u…

  • Continuous quality evaluation of the Asanté rapid test for recent infection for robust kit lot quality verification

    Open Access•Amy Zheng, Mervi Detorio et al.•EDITOR•ARTICLE•PLOS Global Public Health•2024

    The Sedia Biosciences Asanté rapid test for recent infection (RTRI) can identify HIV infections and characterize HIV-1 as recent or long-term infection via the positive verification (V) line and long-term line (LT) line, respectively. Tracking with Recency Assays to Control the Epidemic (TRACE) program uses RTRI assays. Successful implementation of TRACE requires high-quality test performance. The goal of this study is to evaluate the additional …

  • Does enhanced HIV prevention, diagnosis, and linkage to care reduce hospitalisation in high HIV-burden communities in Zambia and South Africa? findings from the HPTN 071 (PopART) randomised trial

    Open Access•Ronelle Burger, Nomtha Bell‐Mandla et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    The objective of this study is to explore if a community-based HIV combination prevention intervention reduced inpatient hospitalisations in Zambia and South Africa by diagnosing HIV and TB in earlier stages of disease progression, thereby preventing severe disease and new infections. As part of the HIV Prevention Trials Network (HPTN) 071 trial, hospitalisation data from a cohort of 16 968 consenting randomly sampled adults aged 18–44 years were…

  • High prevalence of undocumented Sars-CoV-2 infections revealed by analysis of nucleocapsid-specific IgG responses in diagnosed and undiagnosed individuals

    Open Access•Kim Blom, Ilias Galanis et al.•EDITOR•ARTICLE•PLOS Global Public Health•2025

    Acute SARS-CoV-2 infections are not always diagnosed; hence an unknown proportion of all infections are not documented. SARS-CoV-2 can induce spike and nucleocapsid protein specific IgG antibodies, which can be detected in seroprevalence studies to identify a previous infection. However, with the introduction of vaccines containing the spike protein it is no longer possible to use spike-IgG as a marker of infection. In many countries marketed vac…

  • Trends in advanced HIV disease, treatment interruption, and viraemia in KwaZulu-Natal, South Africa

    Open Access•Sanele S Mbeje, Lilishia Gounder et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    Advanced HIV disease (AHD), treatment interruption and viraemia remain key challenges to effectiveness of HIV programmes in South Africa. Understanding the trends of these measures and their variation across geographic regions can inform more targeted and responsive interventions. We conducted a retrospective cohort study using routine, de-identified data from TIER.Net, a national HIV electronic register. We curated data from 116 primary care cli…

  • Decade-long antiretroviral therapy in Uganda

    Open Access•Maria Magdalene Namaganda, Stathis Gennatas et al.•EDITOR•ARTICLE•PLOS Global Public Health•2026

    The scale-up of antiretroviral therapy (ART) has transformed the HIV epidemic in sub-Saharan Africa, yet longitudinal public health insights from national programmatic cohorts remain scarce. As global targets move toward epidemic control and elimination of virological failure, understanding how profiles and outcomes of people living with HIV (PLWH) evolve in real-world settings is essential. The AIDS Support Organisation (TASO), Uganda’s largest …

Medicine (10 works) · HIV/AIDS Research and Interventions (6 works) · Immunology (6 works) · Internal Medicine (6 works) · Environmental health (5 works) · HIV, Drug Use, Sexual Risk (5 works) · Cohort (4 works) · Demography (4 works) · Antiretroviral therapy (3 works) · Biology (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae